Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news
    • US shows interest in...

    US shows interest in potential coronavirus vaccine developer CureVac, Germany stakes claim

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-03-17T13:00:14+05:30  |  Updated On 17 March 2020 1:00 PM IST
    US shows interest in potential coronavirus vaccine developer CureVac, Germany stakes claim

    Berlin: Germany staked its claim Sunday to ongoing work into a vaccine against the coronavirus, after media reports claimed US President Donald Trump was trying to poach research from a German company.

    "The German government has a strong interest in producing vaccines in Germany and Europe," a spokesperson for the economy ministry told media group, Funke.

    The ministry also pointed out that the government had the power to scrutinise foreign takeovers of German companies, "especially when it comes to national or European security".

    According to a report in the Welt am Sonntag newspaper, Trump is trying to secure exclusive rights to a potential vaccine against the global health threat that has now killed some 6,000 people, which is being worked on by biotech firm CureVac.

    The vaccine would then be "only for the United States," a source close to the German government told Die Welt, whose front page on Sunday read "Trump vs Berlin".

    Yet a US official told AFP Sunday that the report was "wildly overplayed".

    "The US government has spoken with many (more than 25) companies that claim they can help with a vaccine. Most of these companies already received seed funding from US investors."

    The official also denied that the US was seeking to keep any potential vaccine for itself.

    "We will continue to talk to any company that claims to be able to help. And any solution found would be shared with the world."

    CureVac investors also told German media that they would not sell the vaccine to a single state.

    "We want to develop a vaccine for the whole world," said Christof Hettich, CEO of CureVac's primary investor dievini Hopp Biotech Holding.

    CureVac, founded in 2000, is based in the German state of Thuringia and has other sites in Frankfurt and Boston.

    The firm markets itself as specialising in "development of treatments against cancer, antibody-based therapies, treatment of rare illnesses and prophylactic vaccines."

    The lab is currently working in tandem with the Paul-Ehrlich Institute, linked to the German health ministry.

    Last week, the firm announced that CEO Daniel Menichella had been replaced by Ingmar Hoerr, just weeks after Menichella met with Trump, his vice-president Mike Pence and representatives of pharma companies in Washington.

    "We are very confident that we will be able to develop a potent vaccine candidate within a few months," CureVac quoted Menichella as saying on its website shortly after the visit.

    Read also: Roche gets USFDA Emergency Use Authorization for its Cobas SARS-CoV-2 Test

    donald-trumpbiotechcurevaccoronaviruscovid-19christof-hettich
    Source : AFP

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok